Giourou E, et al. Introduction to epilepsy and related brain disorders. In: Cyberphysical systems for epilepsy and related brain disorders. Cham: Springer; 2015. p. 11–38.
Jaiswal G, Kumar P. Neuroprotective role of apocynin against pentylenetetrazole kindling epilepsy and associated comorbidities in mice by suppression of ROS/RNS. Behav Brain Res. 2022;419:113699.
Article CAS PubMed Google Scholar
Anwar H, et al. Epileptic seizures Discoveries (Craiova). 2020;8(2):e110.
Siddiqui MA, et al. Resveratrol loaded nanoparticles attenuate cognitive impairment and inflammatory markers in PTZ-induced kindled mice. Int Immunopharmacol. 2021;101(Pt A):108287.
Article CAS PubMed Google Scholar
Kavaye Kandeda A, et al. Pergularia daemia hydro-ethanolic extract protects against pentylenetetrazole kindling-induced seizures, oxidative stress, and neuroinflammation in mice. J Ethnopharmacol. 2021;279:114338.
Article CAS PubMed Google Scholar
Mao XY, Zhou HH, Jin WL. Redox-related neuronal death and crosstalk as drug targets: focus on epilepsy. Front Neurosci. 2019;13:512.
Article PubMed PubMed Central Google Scholar
El-Missiry MA, et al. Nanoformulated ellagic acid ameliorates pentylenetetrazol-induced experimental epileptic seizures by modulating oxidative stress, inflammatory cytokines and apoptosis in the brains of male mice. Metab Brain Dis. 2020;35(2):385–99.
Article CAS PubMed Google Scholar
Babazadeh A, Mohammadi Vahed F, Jafari SM. Nanocarrier-mediated brain delivery of bioactives for treatment/prevention of neurodegenerative diseases. J Control Release. 2020;321:211–21.
Article CAS PubMed Google Scholar
de Lima LS, Mortari MR. Therapeutic nanoparticles in the brain: A review of types, physicochemical properties and challenges. Int J Pharm. 2022;612:121367.
Han L, Jiang C. Evolution of blood-brain barrier in brain diseases and related systemic nanoscale brain-targeting drug delivery strategies. Acta Pharm Sin B. 2021;11(8):2306–25.
Article CAS PubMed Google Scholar
Prager O, et al. Seizure-induced microvascular injury is associated with impaired neurovascular coupling and blood-brain barrier dysfunction. Epilepsia. 2019;60(2):322–36.
Article CAS PubMed Google Scholar
Sweeney MD, Sagare AP, Zlokovic BV. Blood-brain barrier breakdown in alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol. 2018;14(3):133–50.
Article CAS PubMed PubMed Central Google Scholar
Li J-J, et al. Electric and reactive oxygen species dual-responsive polymeric micelles improve the therapeutic efficacy of lamotrigine in pentylenetetrazole kindling rats. Colloids Surf A Physicochem Eng Asp. 2022;642:128628.
Fang Z, et al. Pluronic P85-coated poly(butylcyanoacrylate) nanoparticles overcome phenytoin resistance in P-glycoprotein overexpressing rats with lithium-pilocarpine-induced chronic temporal lobe epilepsy. Biomaterials. 2016;97:110–21.
Article CAS PubMed Google Scholar
Aparicio-Blanco J, et al. Lipid nanocapsules decorated and loaded with cannabidiol as targeted prolonged release carriers for glioma therapy: In vitro screening of critical parameters. Eur J Pharm Biopharm. 2019;134:126–37.
Article CAS PubMed Google Scholar
Scioli Montoto S, et al. Carbamazepine-loaded solid lipid nanoparticles and nanostructured lipid carriers: Physicochemical characterization and in vitro/in vivo evaluation. Colloids Surf B Biointerfaces. 2018;167:73–81.
Article CAS PubMed Google Scholar
Mante PK, et al. Solid-lipid nanoparticle formulation improves antiseizure action of cryptolepine. Biomed Pharmacother. 2021;137:111354.
Article CAS PubMed Google Scholar
Rawat M, Yadukrishnan P, Kumar N. Mechanisms of action of nanoparticles in living systems. In: Research anthology on synthesis, characterization, and applications of nanomaterials. IGI Global; 2021. p. 1555–71.
Huynh NT, et al. Lipid nanocapsules: a new platform for nanomedicine. Int J Pharm. 2009;379(2):201–9.
Article CAS PubMed Google Scholar
Albanawany NM, et al. Histopathological, physiological and biochemical assessment of resveratrol nanocapsules efficacy in bleomycin-induced acute and chronic lung injury in rats. Drug Deliv. 2022;29(1):2592–608.
Article CAS PubMed PubMed Central Google Scholar
Roger E, et al. Reciprocal competition between lipid nanocapsules and P-gp for paclitaxel transport across Caco-2 cells. Eur J Pharm Sci. 2010;40(5):422–9.
Article CAS PubMed Google Scholar
Moura RP, et al. Lipid nanocapsules to enhance drug bioavailability to the central nervous system. J Control Release. 2020;322:390–400.
Article CAS PubMed Google Scholar
Carradori D, et al. NFL-lipid nanocapsules for brain neural stem cell targeting in vitro and in vivo. J Control Release. 2016;238:253–62.
Article CAS PubMed Google Scholar
García-Montoya IA, et al. Lactoferrin a multiple bioactive protein: an overview. Biochim Biophys Acta. 2012;1820(3):226–36.
Pereira P, et al. Brain-targeted delivery of Pre-miR-29b using lactoferrin-stearic acid-modified-chitosan/polyethyleneimine polyplexes. Pharmaceuticals. 2020;13(10):314.
Article CAS PubMed PubMed Central Google Scholar
Li YQ, Guo C. A review on lactoferrin and central nervous system diseases. Cells. 2021;10(7):1810.
Article CAS PubMed PubMed Central Google Scholar
Naidu SAG, et al. Lactoferrin for Mental Health: Neuro-Redox Regulation and Neuroprotective Effects across the Blood-Brain Barrier with Special Reference to Neuro-COVID-19. J Diet Suppl. 2023;20(2):218–53.
Article CAS PubMed Google Scholar
van de Looij Y, et al. Lactoferrin during lactation protects the immature hypoxic-ischemic rat brain. Ann Clin Transl Neurol. 2014;1(12):955–67.
Article PubMed PubMed Central Google Scholar
Chen H, et al. Lactoferrin modified doxorubicin-loaded procationic liposomes for the treatment of gliomas. Eur J Pharm Sci. 2011;44(1–2):164–73.
Article CAS PubMed Google Scholar
Zhao C, et al. Design of lactoferrin modified lipid nano-carriers for efficient brain-targeted delivery of nimodipine. Mater Sci Eng C Mater Biol Appl. 2018;92:1031–40.
Article CAS PubMed Google Scholar
Aghdash SN. Herbal Medicine in the Treatment of Epilepsy. Curr Drug Targets. 2021;22(3):356–67.
Article CAS PubMed Google Scholar
Stefanska J, Pawliczak R. Apocynin: molecular aptitudes. Mediators Inflamm. 2008;2008:106507.
留言 (0)